首页 > 市场调查报告书 > 製药

药物开发临床实验临床开发

临床试验用品及耗材市场规模、份额及成长分析（按服务、阶段、类型、治疗领域及地区划分）－2026-2033年产业预测

市场调查报告书

商品编码

1900254

临床试验用品及耗材市场规模、份额及成长分析（按服务、阶段、类型、治疗领域及地区划分）－2026-2033年产业预测

Clinical Trial Materials And Supplies Market Size, Share, and Growth Analysis, By Service (Logistics & Distribution, Storage & Retention), By Phase, By Type, By Therapeutic Area, By Region - Industry Forecast 2026-2033

出版日期: 2025年12月17日 | 出版商:

SkyQuest | 英文 260 Pages | 商品交期: 3-5个工作天内

价格

简介目录

全球临床试验用品和耗材市场预计到 2024 年将达到 38.4 亿美元，到 2025 年将达到 42.2 亿美元，到 2033 年将达到 89.1 亿美元，预测期（2026-2033 年）的复合年增长率为 9.8%。

临床试验耗材管理至关重要，尤其是在药物研发成本不断上涨的情况下，它可以避免库存过期和生产过剩等问题。高效的供应链对于应对复杂的临床研究并遵守监管要求至关重要。临床试验耗材市场的成长动力源自于临床研究数量的增加和复杂性的增加。耗材涵盖了医疗试验所需的各种设备，例如输液帮浦、雾化器和注射针，这些设备用于疾病的诊断和治疗、治疗方法评估以及支援各种医疗程序。随着药物研发企业将临床试验耗材外包给研究机构，在技术进步、供应商之间的策略合作以及专利到期等因素的推动下，该市场正经历加速成长。

全球临床试验用品和耗材市场驱动因素

全球临床试验用品和耗材市场的扩张主要得益于中国、印度和韩国等新兴国家患者参与临床试验的动机不断提高。与已开发国家相比，这些国家的成本显着降低。这些地区能够以更低的成本进行早期临床试验，从而为研究，特别是罕见疾病研究，创造了极具吸引力的环境。此外，技术和数据分析的进步在简化临床试验流程方面发挥关键作用，促使製药和生物技术公司寻求创新解决方案。这种在发展中国家进行临床试验的趋势提高了效率，并促进了产业内的合作。

全球临床试验用品和耗材市场面临的限制因素

全球临床试验用品及耗材市场面临严峻挑战，主要原因是药物研发阶段的高失败率，这给研发带来了沉重的经济负担。罕见疾病研发的复杂性进一步加剧了这一困境，因为成功进行临床试验往往需要专业知识。令人惊讶的是，许多药物，尤其是在肿瘤领域，在完成临床试验后最终未能获得监管部门的核准。此外，从新药发现到上市核准的漫长而昂贵的过程也是阻碍市场整体成长和扩张的主要障碍。

全球临床试验用品和耗材市场趋势

由于生物製剂和温控药物具有许多治疗优势，例如与传统治疗方法相比副作用较少，全球临床试验耗材市场正经历着向生物製药和温控药物的显着转变。生物製药在后期药物研发中占很大比例，大量现有药物也需要在温控环境下保存，因此市场预计将对这些趋势做出积极反应。对低温运输物流日益增长的依赖凸显了供应链中基础设施建设和创新解决方案的必要性，以确保这些敏感产品的完整性和有效性。因此，对低温运输设施和先进监测技术的投资激增预计将重塑未来。

北美洲
- 美国
- 加拿大
欧洲
- 德国
- 西班牙
- 法国
- 英国
- 义大利
- 其他欧洲地区
亚太地区
- 中国
- 印度
- 日本
- 韩国
- 亚太其他地区
拉丁美洲
- 巴西
- 其他拉丁美洲地区
中东和非洲
- 海湾合作委员会国家
- 南非
- 其他中东和非洲地区

竞争资讯

前五大公司对比
主要企业的市场定位（2025 年）
主要市场参与者所采取的策略
近期市场趋势
公司市占率分析（2025 年）
主要企业公司简介
- 公司详情
- 产品系列分析
- 依业务板块进行公司股票分析
2023-2025年营收年比比较

主要企业简介

Lonza Group
Catalent, Inc.
Piramal Pharma Solutions
Almac Group
Parexel International
Eurofins Scientific
Marken（A Subsidiary of UPS）
Thermo Fisher Scientific, Inc.
Sharp Services, LLC
PCI Pharma Services
Nuvisan
Celerion
WuXi AppTec
Recipharm AB
Tunnell Consulting
Aesica Pharmaceuticals
Boehringer Ingelheim
Kendle International（Now a part of INC Research）
Syneos Health
Vetter Pharma

结论与建议

简介目录

Product Code: SQMIG35B2074

Global Clinical Trial Materials And Supplies Market size was valued at USD 3.84 Billion in 2024 and is poised to grow from USD 4.22 Billion in 2025 to USD 8.91 Billion by 2033, growing at a CAGR of 9.8% during the forecast period (2026-2033).

The management of clinical trial supplies is essential to avoid challenges like inventory expiration and overproduction, particularly as the costs of drug detection rise. An efficient supply chain is crucial for navigating the complexities of clinical research while adhering to regulatory demands. The market for clinical trial materials is driven by the increasing number and intricacy of clinical studies. Supplies include various tools vital for medical trials, such as infusion pumps, nebulizers, and syringe needles, used for diagnosing and treating diseases, evaluating therapies, and supporting various medical operations. As drug developers outsource their clinical trial supplies to investigator sites, the market is experiencing accelerated growth, fueled by technological advancements, strategic collaboration among providers, and an uptick in patent expirations.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Clinical Trial Materials And Supplies market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Clinical Trial Materials And Supplies Market Segments Analysis

Global Clinical Trial Materials And Supplies Market is segmented by service, phase, type, therapeutic area, end user and region. Based on service, the market is segmented into logistics & distribution, storage & retention, packaging, labelling & blinding, manufacturing, comparator sourcing and other services. Based on phase, the market is segmented into Phase I, Phase II, Phase III, Phase IV, BA/BE Studies. Based on type, the market is segmented into small-molecules, biologic drugs and medical devices. Based on therapeutic area, the market is segmented into oncology, infectious diseases, neurology, metabolic disorders, immunology, cardiology, genetic diseases and other therapeutic areas. Based on end user, the market is segmented into pharmaceutical and biotechnology companies, contract research organisations (CRO's) and medical device companies. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Clinical Trial Materials And Supplies Market

The expansion of the Global Clinical Trial Materials and Supplies market is significantly driven by an increase in patient participation in clinical trials in emerging nations such as China, India, and South Korea, where costs are substantially lower compared to developed countries. In these regions, early-phase clinical trials can be considerably less expensive, creating an attractive environment for conducting research, particularly for rare diseases. Furthermore, the advancement of technology and data analytics plays a crucial role in streamlining clinical trial processes, encouraging pharmaceutical and biotechnology companies to outsource innovative solutions. This shift towards developing countries for clinical trials enhances efficiency and encourages collaboration within the industry.

Restraints in the Global Clinical Trial Materials And Supplies Market

The Global Clinical Trial Materials and Supplies market faces significant challenges due to the high attrition rates of drug candidates during development, which leads to considerable financial burdens in research and development. The complexity of R&D for rare diseases often requires specialized expertise to successfully conduct clinical trials, further complicating the process. A striking number of drugs, particularly in the field of oncology, fail to secure regulatory approval after reaching clinical testing stages. Furthermore, the lengthy timeline and escalating costs involved in bringing a new drug from discovery to market approval act as major obstacles, hindering the overall growth and expansion of the market.

Market Trends of the Global Clinical Trial Materials And Supplies Market

The Global Clinical Trial Materials and Supplies market is witnessing a notable shift towards biologics and temperature-sensitive medications, driven by their therapeutic advantages, such as lower side effects compared to traditional therapies. With biologics constituting a significant percentage of late-phase pharmaceutical developments and a substantial portion of existing drugs requiring temperature-controlled environments, the market is expected to respond dynamically to these trends. This growing reliance on cold chain logistics underscores the necessity for enhanced infrastructure and innovative solutions in the supply chain to ensure the integrity and efficacy of these sensitive products. As such, investments in cold chain facilities and advanced monitoring technologies are poised to surge, shaping the future landscape of clinical trial materials and supplies.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2025
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Supply Chain Analysis
Technology Analysis
Regulatory Analysis

Global Clinical Trial Materials And Supplies Market Size by Service & CAGR (2026-2033)

Market Overview
Logistics & Distribution
Storage & Retention
Packaging, Labelling & Blinding
Manufacturing
Comparator Sourcing
Other Services

Global Clinical Trial Materials And Supplies Market Size by Phase & CAGR (2026-2033)

Market Overview
Phase I
Phase II
Phase III
Phase IV
BA/BE Studies

Global Clinical Trial Materials And Supplies Market Size by Type & CAGR (2026-2033)

Market Overview
Small-Molecules
Biologic Drugs
Medical Devices

Global Clinical Trial Materials And Supplies Market Size by Therapeutic Area & CAGR (2026-2033)

Market Overview
Oncology
Infectious Diseases
Neurology
Metabolic Disorders
Immunology
Cardiology
Genetic Diseases
Other Therapeutic Areas

Global Clinical Trial Materials And Supplies Market Size by End User & CAGR (2026-2033)

Market Overview
Pharmaceutical And Biotechnology Companies
Contract Research Organisations (CRO's)
Medical Device Companies

Global Clinical Trial Materials And Supplies Market Size & CAGR (2026-2033)

North America (Service, Phase, Type, Therapeutic Area, End User)
- US
- Canada
Europe (Service, Phase, Type, Therapeutic Area, End User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Service, Phase, Type, Therapeutic Area, End User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Service, Phase, Type, Therapeutic Area, End User)
- Brazil
- Rest of Latin America
Middle East & Africa (Service, Phase, Type, Therapeutic Area, End User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

Lonza Group
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Catalent, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Piramal Pharma Solutions
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Almac Group
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Parexel International
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Eurofins Scientific
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Marken (A Subsidiary of UPS)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Thermo Fisher Scientific, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sharp Services, LLC
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
PCI Pharma Services
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Nuvisan
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Celerion
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
WuXi AppTec
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Recipharm AB
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Tunnell Consulting
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Aesica Pharmaceuticals
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Boehringer Ingelheim
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Kendle International (Now a part of INC Research)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Syneos Health
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Vetter Pharma
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments